Ranked 4th in the World in terms of per capita expenditure, Norway represents a mature and wealthy medical device market. In 2004, the market is estimated to be worth US$571.7 million with a per capita spending of US$130. Health policy is centred around a publicly run health service available to the whole population, hindered neither by the individual's geographical location or income. The organisation of the health system has been a topic of debate in recent years. In particular, the central government took over the responsibility of running all public hospitals in 2001, making them into health enterprises. The reform is aimed at improving efficiency and performance within in the hospital sector and generating savings from economies of scale, especially for equipment purchases.

MediSTAT currently reports on over 70 countries in more than 4,000 pages of in-depth market data. Incorporating primary source material with Espicom's vast healthcare business database, MediSTAT provides a complete review of key medical markets. Each extensive report includes vital market data, background information and statistics, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, import & export figures and essential industry contacts.

For a complete index of this report click on http://www.researchandmarkets.com/reports/43016

About Research and Markets Ltd.

Research and Markets Ltd. are Europe's largest resource for market research. R&M distribute thousands of major research publications from the world's leading publishers, consultants and market analysts. R&M provide you with the latest forecasts on international and regional markets, key industries, the top companies, new products and the latest market trends.

For additional information on ResearchandMarkets.com, their range of reports or their value-added services, visit their web site at http://www.researchandmarkets.com or mailto:press@researchandmarkets.com